S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end

Ironwood Pharmaceuticals (IRWD) Short Interest Ratio & Short Volume

$7.92
+0.32 (+4.21%)
(As of 04/19/2024 ET)

Ironwood Pharmaceuticals Short Interest Data

Current Short Volume
21,950,000 shares
Previous Short Volume
18,770,000 shares
Change Vs. Previous Month
+16.94%
Dollar Volume Sold Short
$191.18 million
Short Interest Ratio / Days to Cover
4.6
Last Record Date
March 31, 2024
Outstanding Shares
156,529,000 shares
Float Size
151,600,000 shares
Short Percent of Float
14.48%
Today's Trading Volume
2,532,930 shares
Average Trading Volume
2,579,630 shares
Today's Volume Vs. Average
98%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Ironwood Pharmaceuticals ?

Sign up to receive the latest short interest report for Ironwood Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

IRWD Short Interest Over Time

IRWD Days to Cover Over Time

IRWD Percentage of Float Shorted Over Time

Ironwood Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202421,950,000 shares $191.18 million +16.9%14.5%4.6 $8.71
3/15/202418,770,000 shares $169.31 million +21.0%12.4%4 $9.02
2/29/202415,510,000 shares $146.26 million -0.6%10.2%3.8 $9.43
2/15/202415,600,000 shares $233.84 million +7.9%10.3%5.5 $14.99
1/31/202414,460,000 shares $205.19 million -10.1%9.5%5.4 $14.19
1/15/202416,080,000 shares $195.37 million +2.0%12.8%6.5 $12.15
12/31/202315,760,000 shares $180.29 million -7.3%10.3%7.4 $11.44
12/15/202317,000,000 shares $189.21 million +2.3%11.2%7.8 $11.13
11/30/202316,620,000 shares $164.54 million -3.1%10.9%6.8 $9.90
11/15/202317,150,000 shares $167.38 million -1.4%11.3%6.9 $9.76
10/31/202317,390,000 shares $155.99 million -0.9%11.4%6.7 $8.97
10/15/202317,540,000 shares $164.00 million -0.6%11.5%6.8 $9.35
9/30/202317,640,000 shares $169.87 million +20.3%11.6%7.1 $9.63
9/15/202314,660,000 shares $122.26 million -5.4%9.6%6.1 $8.34
8/31/202315,500,000 shares $136.40 million +3.9%10.2%7.2 $8.80
8/15/202314,920,000 shares $147.11 million -1.8%9.8%7.1 $9.86
7/31/202315,190,000 shares $168.46 million -6.5%10.0%7.3 $11.09
7/15/202316,250,000 shares $168.35 million +13.5%10.7%7.9 $10.36
6/30/202314,320,000 shares $152.36 million -17.9%9.5%6.4 $10.64
6/15/202317,450,000 shares $192.47 million -1.0%11.5%7 $11.03
5/31/202317,620,000 shares $191.71 million +6.4%11.6%7.3 $10.88
5/15/202316,560,000 shares $174.38 million -3.3%10.9%6.7 $10.53
4/30/202317,130,000 shares $178.32 million -14.9%11.3%7.3 $10.41
4/15/202320,130,000 shares $221.23 million +14.1%13.4%8.8 $10.99
3/31/202317,640,000 shares $185.57 million +8.0%11.8%7.6 $10.52
3/15/202316,330,000 shares $170.32 million +1.0%10.9%8.4 $10.43
2/28/202316,170,000 shares $182.24 million +1.4%10.7%8.3 $11.27
2/15/202315,950,000 shares $178.64 million -0.1%10.6%8.4 $11.20
1/31/202315,970,000 shares $183.97 million +0.1%10.7%8.5 $11.52
1/15/202315,950,000 shares $184.86 million -2.6%10.7%8.7 $11.59
12/30/202216,370,000 shares $202.82 million -3.4%10.9%8.8 $12.39
12/15/202216,950,000 shares $204.25 million +2.8%11.4%8.9 $12.05
11/30/202216,490,000 shares $199.69 million -12.3%11.1%8.2 $12.11
11/15/202218,810,000 shares $214.62 million +9.7%12.6%8.9 $11.41
10/31/202217,150,000 shares $187.62 million -1.6%11.4%8.1 $10.94
10/15/202217,420,000 shares $175.77 million +0.2%11.7%7.5 $10.09
9/30/202217,390,000 shares $180.16 million -3.3%11.7%7.5 $10.36
9/15/202217,980,000 shares $196.16 million -1.1%12.1%7.6 $10.91
8/31/202218,170,000 shares $195.51 million -0.4%12.2%6 $10.76
8/15/202218,240,000 shares $217.24 million +0.9%12.3%5.5 $11.91
SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

IRWD Short Interest - Frequently Asked Questions

What is Ironwood Pharmaceuticals' current short interest?

Short interest is the volume of Ironwood Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 21,950,000 shares of IRWD short. 14.48% of Ironwood Pharmaceuticals' shares are currently sold short. Learn More on Ironwood Pharmaceuticals' current short interest.

What is a good short interest ratio for Ironwood Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IRWD shares currently have a short interest ratio of 5.0. Learn More on Ironwood Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Ironwood Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ironwood Pharmaceuticals: Barclays PLC, Citadel Advisors LLC, Balyasny Asset Management L.P., and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Ironwood Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.48% of Ironwood Pharmaceuticals' floating shares are currently sold short.

Is Ironwood Pharmaceuticals' short interest increasing or decreasing?

Ironwood Pharmaceuticals saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 21,950,000 shares, an increase of 16.9% from the previous total of 18,770,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Ironwood Pharmaceuticals' float size?

Ironwood Pharmaceuticals currently has issued a total of 156,529,000 shares. Some of Ironwood Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ironwood Pharmaceuticals currently has a public float of 151,600,000 shares.

How does Ironwood Pharmaceuticals' short interest compare to its competitors?

14.48% of Ironwood Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Ironwood Pharmaceuticals: MannKind Co. (13.21%), Ligand Pharmaceuticals Incorporated (4.05%), Dynavax Technologies Co. (13.73%), Innoviva, Inc. (18.15%), OPKO Health, Inc. (28.56%), Cryoport, Inc. (8.57%), IGM Biosciences, Inc. (25.10%), Geron Co. (8.53%), Lexicon Pharmaceuticals, Inc. (8.90%), Amicus Therapeutics, Inc. (11.00%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Ironwood Pharmaceuticals stock?

Short selling IRWD is an investing strategy that aims to generate trading profit from Ironwood Pharmaceuticals as its price is falling. IRWD shares are trading up $0.32 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Ironwood Pharmaceuticals?

A short squeeze for Ironwood Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IRWD, which in turn drives the price of the stock up even further.

How often is Ironwood Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IRWD, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:IRWD) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners